DrugPatentWatch Database Preview
Drugs Containing Excipient (Inactive Ingredient) ANHYDROUS DIBASIC CALCIUM PHOSPHATE
» See Plans and Pricing
Branded drugs containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE excipient, and estimated key patent expiration / generic entry dates
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Merck Sharp & Dohme Corp. | JANUVIA | sitagliptin | 0006-0221 | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | 2027-05-24 |
| Merck Sharp & Dohme Corp. | JANUVIA | sitagliptin | 0006-0221 | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | 2027-05-24 |
| Merck Sharp & Dohme Corp. | JANUVIA | sitagliptin | 0006-0221 | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | 2027-05-24 |
| Merck Sharp & Dohme Corp. | JANUVIA | sitagliptin | 0006-0221 | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | 2027-05-24 |
| Merck Sharp & Dohme Corp. | JANUVIA | sitagliptin | 0006-0221 | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | 2027-05-24 |
| Merck Sharp & Dohme Corp. | JANUVIA | sitagliptin | 0006-0221 | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | 2027-05-24 |
| Merck Sharp & Dohme Corp. | JANUVIA | sitagliptin | 0006-0221 | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | 2027-05-24 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Generic drugs containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE excipient
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2021 - 2022
NCE-1 Patent Challenge Dates 2021 - 2022
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2021, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
